Your browser doesn't support javascript.
loading
A Prospective Controlled Trial to Evaluate Safety and Efficacy of in vitro Expanded Recipient Regulatory T Cell Therapy and Tocilizumab Together With Donor Bone Marrow Infusion in HLA-Mismatched Living Donor Kidney Transplant Recipients (Trex001).
Oberbauer, Rainer; Edinger, Matthias; Berlakovich, Gabriela; Kalhs, Peter; Worel, Nina; Heinze, Georg; Wolzt, Michael; Lion, Thomas; Wekerle, Thomas.
Afiliação
  • Oberbauer R; Division of Nephrology and Dialysis, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
  • Edinger M; University Hospital Regensburg, Department of Internal Medicine III & Regensburg Center for Interventional Immunology (RCI), Regensburg, Germany.
  • Berlakovich G; Division of Transplantation, Department of Surgery, Medical University of Vienna, Vienna, Austria.
  • Kalhs P; Bone Marrow Transplant Unit, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.
  • Worel N; Department of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Vienna, Austria.
  • Heinze G; Section for Clinical Biometrics, Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Vienna, Austria.
  • Wolzt M; Clinical Trials Coordination Centre, Medical University of Vienna, Vienna, Austria.
  • Lion T; St. Anna Children's Cancer Research Institute, Vienna, Austria.
  • Wekerle T; Ludwig Boltzmann Institute for Hematology & Oncology, Medical University of Vienna, Vienna, Austria.
Front Med (Lausanne) ; 7: 634260, 2020.
Article em En | MEDLINE | ID: mdl-33585521
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Risk_factors_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Risk_factors_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article